Annual result: details
in CHF
2021
2020
ASSETS
Liquid assets
2'626'809
2'267'297
Securities
25'916'138
22'644'390
Accounts receivable
1'632'152
2'254'162
Other current receivables
124'826
211'456
Accruals
325'867
468'243
Current assets
30'625'792
27'845'548
Movable tangible assets
170'148
235'315
Intangible fixed assets
344'963
440'909
Fixed assets
515'111
676'224
ASSETS
31'140'903
28'521'772
LIABILITIES
Accounts payable
1'256'860
1'431'504
Other current liabilities
668'827
643'649
Deferrals
1'060'248
1'085'860
Short-term liabilities
2'985'935
3'161'013
Long-term provisions
1'034'789
1'034'789
Fund capital
10'922'735
10'683'610
Long-term liabilities
11'957'524
11'718'399
Capital stock
2'000'000
2'000'000
Statutory retained earnings
840'130
840'130
Unrestricted capital
442'800
390'628
Annual result
35'084
52'172
Equity capital-Organisational capital
16'197'444
13'642'360
LIABILITIES
31'140'903
28'521'772
Statement of accounts
in CHF
2021
2020
Income from donations, other contributions
2'902'079
2'878'543
Income from public remit
567'078
664'923
Income from donor searches and transplants
15'264'840
14'517'119
Income from commerce
-
715
Income from services
1'012'535
832'123
Income from project contributions of charitable organisations,
non-profit organisations
1'775'621
1'938'891
Operating income
21'522'153
20'832'314
Expenditure on national assigned duties
-13'653
-117'136
Cost of donor recruitment and care
-757'605
-1'132'065
Cost of donor searches and transplants
-8'317'110
-7'017'949
Expenditure materials and services
-1'503'786
-1'675'321
Staff costs
-6'352'413
-6'363'638
Other operating result
-1'462'452
-1'712'306
Expenditure – administration, consulting, and IT
-1'451'304
-1'478'131
Depreciation
-287'075
-197'907
Total operating expenditure
20'145'398
-19'694'453
Operating result
1'376'755
1'137'861
Financial expense
-484'325
-437'365
Financial income
1'901'779
1'179'838
Net financial income
1'417'454
742'473
Annual result before change in fund capital
2'794'209
1'880'334
Transfer to fund capital
-2'928'821
-2'988'413
Use of fund capital
2'689'696
3'050'251
Annual result before change in capital of the organisation
2'555'084
1'942'172
Change in organisational capital
-2'520'000
-1'890'000
Annual result
35'084
52'172
Solidarity fund
In 2021, the fund paid out a total of CHF 494,400. These payments helped to ease the difficult financial situations of 26 HIV patients, or their families, and of 2 people infected with hepatitis.
Solidarity Fund Blood
The solidarity fund Blood was set up by the Swiss Red Cross in 1993. The payments from this fund are intended to ease the suffering of people who have been infected with dangerous diseases through blood products. The large majority of these patients were infected with HIV or hepatitis C in the 1980s or early 1990s. Through this fund, which was set up specifically for this purpose, the Swiss Red Cross pays tribute to the solidarity felt for people harmed by blood products received via transfusions. Payment of benefits from the fund is a voluntary undertaking, as neither Swiss Transfusion SRC nor the Swiss Red Cross can be held responsible for the residual risk associated with blood products.
Accounts 2021 Solidarity Fund Blood
in CHF
2021
2020
Accounts
494'400
492'150
Staff costs
20'000
20'000
Material expenditure
32'300
35'020
Total expenditure
546'700
547'170
SRC Humanitarian Foundation
650'000
650'000
Additional revenue
9'000
2'250
Total income
659'000
652'250
Surplus
112'300
105'080
Financial position at 31.12.
Assets 1.1.
2'376'771
2'271'691
Surplus 2020
112'300
105'080
Assets 31.12.
2'489'071
2'376'771